According to ChainCatcher, GMGN data shows that the first BioAgent Launch project of Bio Protocol, Aubrai, saw its market capitalization on the Base network briefly surpass 20 million USD before falling back, and is now reported at 9 million USD, with a trading volume of 6.4 million USD within three hours of launch.